Endocrine effects of relaxin overexpression in mice

Endocrinology

Volumn 147, Issue 1, 2006, Pages 407-414

  Feng, Shu ^a   Bogatcheva, Natalia V ^a   Kamat, Aparna A ^a,b   Truong, Anne ^a   Agoulnik, Alexander I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; G PROTEIN COUPLED RECEPTOR; HORMONE RECEPTOR; HYDROXYPROLINE; INSULIN; METALLOPROTEINASE; NITRIC OXIDE; RELAXIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLLAGEN METABOLISM; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOCRINOLOGY; FEMALE; GENE DELETION; GENE OVEREXPRESSION; HYPERTROPHY; LIVER METABOLISM; MALE; MOUSE; NIPPLE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN INTERACTION; TRANSGENIC MOUSE;

ANIMALS; BASE SEQUENCE; BODY WEIGHT; COLLAGEN; DNA PRIMERS; FEMALE; HYDROXYPROLINE; INSULIN; LIVER; MALE; MICE; MICE, TRANSGENIC; ORGAN SIZE; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RATS; RELAXIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 29344434935     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2005-0626     Document Type: Article

References (28)

1. Bathgate RA, Samuel CS, Burazin TC, Gundlach AL, Tregear GW 2003 Relaxin: new peptides, receptors and novel actions. Trends Endocrinol Metab 14:207-213
2. Sherwood OD 2004 Relaxin's physiological roles and other diverse actions. Endocr Rev 25:205-234
3. Fields PA, Larkin LH 1980 Enhancement of uterine cervix extensibility in oestrogen-primed mice following administration of relaxin. J Endocrinol 87:147-152
4. Zaleski HM, Winn RJ, Jennings RL, Dziuk PJ, Sherwood OD 1995 Effects of relaxin administration in early gestation or prior to mating on uterine length and fetal survival in gilts. Biol Reprod 52:1389-1394
5. Hayes ES, Curnow EC, Trounson AO, Danielson LA, Unemori EN 2004 Implantation and pregnancy following in vitro fertilization and the effect of recombinant relaxin administration in Macaca fascicularis. Biol Reprod 71:1591-1597
6. Hwang JJ, Lee AB, Fields PA, Haab LM, Mojonnier LE, Sherwood OD 1991 Monoclonal antibodies specific for rat relaxin. Endocrinology 129:3034-3042
7. Summerlee AJ, Ramsey DG, Poterski RS 1998 Neutralization of relaxin within the brain affects the timing of birth in rats. Endocrinology 139:479-484
8. Steinetz BG, Sherwood OD, Lasano S, Horton L, Bosland MC 2004 Immunoneutralization of circulating relaxin does not alter the breast cancer-protective action of parity in MNU-treated rats. J Exp Ther Oncol 4:59-68
9. Zhao S, Sherwood OD 2004 Induction of labor with RU 486 (mifepristone) in relaxin-deficient rats: antepartum administration of relaxin facilitates delivery and increases pup survival. Am J Obstet Gynecol 190:229-238
10. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, Hsueh AJ 2002 Activation of orphan receptors by the hormone relaxin. Science 295:671-674
11. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Bathgate RA, Sherwood OD, Hsueh AJ 2003 Relaxin signaling in reproductive tissues. Mol Cell Endocrinol 202:165-170
12. Zhao L, Roche PJ, Gunnersen JM, Hammond VE, Tregear GW, Wintour EM, Beck F 1999 Mice without a functional relaxin gene are unable to deliver milk to their pups. Endocrinology 140:445-453
13. Zhao L, Samuel CS, Tregear GW, Beck F, Wintour EM 2000 Collagen studies in late pregnant relaxin null mice. Biol Reprod 63:697-703
14. Samuel CS, Tian H, Zhao L, Amento EP 2003 Relaxin is a key mediator of prostate growth and male reproductive tract development. Lab Invest 83:1055-1067
15. Samuel CS, Zhao C, Bond CP, Hewitson TD, Amento EP, Summers RJ 2004 Relaxin-1-deficient mice develop an age-related progression of renal fibrosis. Kidney Int 65:2054-2064
16. Du XJ, Samuel CS, Gao XM, Zhao L, Parry LJ, Tregear GW 2003 Increased myocardial collagen and ventricular diastolic dysfunction in relaxin deficient mice: a gender-specific phenotype. Cardiovasc Res 57:395-404
17. Kamat AA, Feng S, Bogatcheva NV, Truong A, Bishop CE, Agoulnik AI 2004 Genetic targeting of relaxin and insulin-like factor 3 receptors in mice. Endocrinology 145:4712-4720
18. Krajnc-Franken MA, van Disseldorp AJ, Koenders JE, Mosselman S, van Duin M, Gossen JA 2004 Impaired nipple development and parturition in LGR7 knockout mice. Mol Cell Biol 24:687-696
19. Kumagai J, Hsu SY, Matsumi H, Roh JS, Fu P, Wade JD, Bathgate RA, Hsueh AJ 2002 INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 277:31283-31286
20. Bogatcheva NV, Truong A, Feng S, Engel W, Adham IM, Agoulnik AI 2003 GREAT/LGR8 is the only receptor for insulin-like 3 peptide. Mol Endocrinol 17:2639-2646
21. Feng S, Bogatcheva NV, Kamat AA, Agoulnik AI 2005 Genetic targeting of relaxin and Insl3 signaling in mice. Ann NY Acad Sci 1041:82-90
22. Conrad KP, Novak J 2004 Emerging role of relaxin in renal and cardiovascular function. Am J Physiol 287:R250-R261
23. Silvertown JD, Summerlee AJ, Klonisch T 2003 Relaxin-like peptides in cancer. Int J Cancer 107:513-519
24. Nef S, Parada LF 1999 Cryptorchidism in mice mutant for Insl3. Nat Genet 22:295-299
25. Silver L 1995 Mouse genetics. New York: Oxford University Press; 66
26. Pepper MS 2001 Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21:1104-1117
27. Reddy GK, Enwemeka CK 1996 A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 29:225-229
28. Halls ML, Bond CP, Sudo S, Kumagai J, Ferraro T, Layfield S, Bathgate RA, Summers RJ 2005 Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). J Pharmacol Exp Ther 313:677-687